Unique ID issued by UMIN | UMIN000049448 |
---|---|
Receipt number | R000056263 |
Scientific Title | Effect amino acid mixture on blood glucose - a randomized placebo controlled double blind cross-over study- |
Date of disclosure of the study information | 2022/11/07 |
Last modified on | 2023/09/27 17:35:08 |
Effect of amino acid mixture on blood glucose
Effect of amino acid mixture on blood glucose
Effect amino acid mixture on blood glucose - a randomized placebo controlled double blind cross-over study-
Effect amino acid mixture on blood glucose
Japan |
healthy adult
Not applicable | Adult |
Others
NO
To examines the effect of amino acid mixture on blood glucose
Efficacy
Confirmatory
Not applicable
Blood glucose levels
Plasma insulin levels
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
Food |
amino acid mixture,
single dose
foods not containing amino acid mixture,
single dose
20 | years-old | <= |
65 | years-old | > |
Male and Female
(1)(Healthy) males and females aged between 20 to 64 years old.
(2)Subjects whose fasting blood glucose levels are from 100 mg/dL to 125 mg/dL, or OGTT test (after 2hours) blood glucose levels are from 140mg/dL to 199mg/dL.
(3)Not heavy alcoholic drinker. (Subjects who can stop drinking from 2 days before each measurement.)
(4) Subjects who can make self-judgment and are voluntarily giving written consent form.
(1)Subjects who use oral medication affecting blood glucose.
(2)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting blood glucose.
(3)Subjects who need medical treatment for diabetes.
(4)Subjects who contract or are under treatment or are medical history for serious diseases (e.g.,liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder.
(5)Subjects who have a operational history of digestive disease affecting digestion and absorption.
(6)Subjects who are judged as unsuitable for the study based on the results of blood tests by the investigator at screening.
(7)Subjects who have donated 400 mL of blood within 12 weeks prior to the start of the study and 200 mL of blood within 4 weeks and component blood donations (plasma component and platelet component blood donations) within 2 weeks prior to the start of the study. Also, considering the total amount of blood collected during the study, those who plan to donate blood within 12 weeks of the study.
(8)Subjects who are diagnosed as anemic and not suitable for frequent collection of blood.
(9)Subjects who developed diarrhea or took antibiotics within one week retroactive to the examination.
(10)Subjects who are planning to participate in other clinical studies.
(11)Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating.
(12)Subjects who are judged as unsuitable for the study by the investigator for other reasons.
30
1st name | Yuji |
Middle name | |
Last name | Suda |
Ajinomoto Co., Inc.
Healthcare Food Development Group Wellness Value Creation Center Institute of Food Sciences and Technologies
210-8681
1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan
044-223-4168
yuuji.suda.53c@asv.ajinomoto.com
1st name | kyoko |
Middle name | |
Last name | miura |
Ajinomoto Co., Inc.
Healthcare Food Development Group Wellness Value Creation Center Institute of Food Sciences and Tech
210-8681
1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan
07043255184
Kyouko.miura.jt9@asv.ajinomoto.com
KSO Corporation
Ajinomoto Co., Inc.
Profit organization
KSO Corporation
Ethics Committee of Ajinomoto Co., Ltd
1-15-1,Kyobashi, Chuo-ku, Tokyo
+81-3-5250-8134
ajinomoto_irb@ajinomoto.com
NO
株式会社ケイ・エス・オー(東京都)
KSO Co., Ltd. (Tokyo)
2022 | Year | 11 | Month | 07 | Day |
Unpublished
The study itself was not established, and the material could not be properly evaluated. Randomization may have failed due to large group (order of intake) differences in blood glucose concentration and delta AUC, Cmax, and delta cmax at 30-90 minutes after the loading meal.
2023 | Year | 09 | Month | 27 | Day |
Preinitiation
2022 | Year | 09 | Month | 22 | Day |
2022 | Year | 09 | Month | 22 | Day |
2022 | Year | 12 | Month | 05 | Day |
2023 | Year | 03 | Month | 31 | Day |
2022 | Year | 11 | Month | 07 | Day |
2023 | Year | 09 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056263
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |